BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,165,073 | – | 136,859 | – | 0.03% | – |
| Q2 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $3,741 | -99.9% | 83,613 | -3.0% | 0.03% | -29.3% |
| Q3 2022 | $4,862,000 | -17.6% | 86,170 | -4.6% | 0.04% | -14.6% |
| Q2 2022 | $5,898,000 | -7.5% | 90,299 | +11.2% | 0.05% | +4.3% |
| Q1 2022 | $6,378,000 | -4.4% | 81,179 | +3.5% | 0.05% | -6.1% |
| Q4 2021 | $6,674,000 | -0.4% | 78,446 | -3.8% | 0.05% | +22.5% |
| Q3 2021 | $6,704,000 | -11.4% | 81,569 | -19.1% | 0.04% | -11.1% |
| Q2 2021 | $7,567,000 | -28.4% | 100,863 | -16.2% | 0.04% | -28.6% |
| Q1 2021 | $10,573,000 | +6.8% | 120,328 | -3.4% | 0.06% | 0.0% |
| Q4 2020 | $9,900,000 | -4.9% | 124,506 | -3.0% | 0.06% | -17.1% |
| Q3 2020 | $10,408,000 | -7.5% | 128,358 | +1.8% | 0.08% | -12.6% |
| Q2 2020 | $11,246,000 | +12.7% | 126,075 | +17.4% | 0.09% | -5.4% |
| Q1 2020 | $9,979,000 | -4.0% | 107,388 | -6.3% | 0.09% | +16.5% |
| Q4 2019 | $10,393,000 | +7.8% | 114,657 | -5.9% | 0.08% | +3.9% |
| Q3 2019 | $9,638,000 | -2.7% | 121,876 | +1.7% | 0.08% | -3.8% |
| Q2 2019 | $9,901,000 | +3.1% | 119,799 | +0.0% | 0.08% | +1.3% |
| Q1 2019 | $9,602,000 | +9.5% | 119,794 | -4.1% | 0.08% | +5.4% |
| Q4 2018 | $8,771,000 | -13.8% | 124,858 | -15.7% | 0.07% | -9.8% |
| Q3 2018 | $10,180,000 | -21.4% | 148,113 | -14.5% | 0.08% | -9.9% |
| Q2 2018 | $12,954,000 | +9.0% | 173,303 | -2.3% | 0.09% | +7.1% |
| Q1 2018 | $11,886,000 | -3.8% | 177,466 | +0.8% | 0.08% | +3.7% |
| Q4 2017 | $12,352,000 | +43.8% | 176,111 | +32.4% | 0.08% | +32.3% |
| Q3 2017 | $8,587,000 | +4.9% | 132,989 | +1.9% | 0.06% | +1.6% |
| Q2 2017 | $8,188,000 | +10.6% | 130,540 | -2.3% | 0.06% | +8.9% |
| Q1 2017 | $7,404,000 | +17.8% | 133,597 | -1.3% | 0.06% | +12.0% |
| Q4 2016 | $6,285,000 | -16.2% | 135,307 | -13.0% | 0.05% | -21.9% |
| Q3 2016 | $7,497,000 | -18.9% | 155,485 | -19.0% | 0.06% | -20.0% |
| Q2 2016 | $9,243,000 | +12.5% | 191,978 | -0.3% | 0.08% | +9.6% |
| Q1 2016 | $8,219,000 | +53.8% | 192,532 | +30.4% | 0.07% | +40.4% |
| Q4 2015 | $5,344,000 | -19.5% | 147,622 | -26.9% | 0.05% | -17.5% |
| Q3 2015 | $6,636,000 | -75.7% | 202,021 | -48.2% | 0.06% | -46.2% |
| Q2 2015 | $27,274,000 | +98.7% | 390,044 | +94.6% | 0.12% | +0.9% |
| Q1 2015 | $13,728,000 | -54.2% | 200,400 | -51.0% | 0.12% | -10.8% |
| Q4 2014 | $29,966,000 | +104.3% | 408,862 | +100.1% | 0.13% | 0.0% |
| Q3 2014 | $14,667,000 | -7.8% | 204,359 | -7.1% | 0.13% | -3.7% |
| Q2 2014 | $15,910,000 | -26.4% | 220,057 | -25.1% | 0.14% | -18.7% |
| Q1 2014 | $21,621,000 | -0.8% | 293,858 | -6.2% | 0.17% | -1.8% |
| Q4 2013 | $21,791,000 | -6.0% | 313,319 | -11.2% | 0.17% | +5.0% |
| Q3 2013 | $23,189,000 | +25.5% | 353,013 | +32.3% | 0.16% | +6.6% |
| Q2 2013 | $18,478,000 | – | 266,751 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |